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Abstract 
Background: Increased vascular permeability is a char-
acteristic feature of sepsis which, in the past, has been
ascribed  exclusively  to  a  malfunction  of  endothelial
cells. However, recently it has become evident that the
endothelial glycocalyx is of considerable importance
concerning various aspects of vascular physiology, e.g.
the  vascular  barrier  and  inflammation.  Heparan  sul-
fate, one of its essential components is characteristi-
cally traceable in blood, in case the endothelial glyco-
calyx is damaged or destroyed. 
Methods: In 15 pigs we investigated whether the ad-
ministration of endotoxin from gram-negative bacte-
ria (Escherichia coli) results in increased serum levels
of heparan sulfate, signalizing a shedding of the gly-
cocalyx. In addition, markers of inflammation (white
blood cell count, platelet count, tumour necrosis fac-
tor-a and interleukin-6) were evaluated over an obser-
vation period of 6 hours.
Results: Serum heparan sulfate concentrations signifi-
cantly increased over time in the endotoxin group and
were significantly elevated in comparison to the con-
trol group 6 hours after administration of endotoxin
(p<0.001). In the endotoxin group all markers of in-
flammation  significantly  changed  during  the  time
course. 
Conclusions: the administration of bacterial endotoxin
induced a significant rise in degradation products of
the endothelial glycocalyx.
Key words: Glycocalyx; Sepsis; Heparan Sulfate; leuko-
cyte adhesion, Endotoxin
IntRoduCtIon
a  healthy  vascular  endothelium  is  coated  by  an  en-
dothelial glycocalyx (EGx), which, in some regions of
the vascular bed, has proved to be even thicker than
the endothelial cells [1]. this EGx consists of extra-
cellular domains of molecules such as transmembrane
syndecans  and  membrane-bound  glypicans  that  both
contain  covalently  bound,  highly  negatively  charged
glycosaminoglycans (GaGs), mainly heparan sulphate
[2, 3]. the physiological importance of the endothelial
glycocalyx has not been realized for many years, but re-
cent evidence has shown the EGx to play a key role
concerning various aspects of vascular physiology.
the EGx has considerable influence on transvas-
cular fluid exchange [1, 4]. thus, it has been identified
as a competent barrier against extravasation of fluids
and colloids [1, 4-6]. the EGx is involved in inflam-
matory processes and immune reactions [7, 8] and me-
diates the release of vasoregulatory agents such as ni-
tric oxid [9-11]. another important biological property
of  the  EGx  may  be  the  ability  to  keep  circulating
blood cells in distance to the endothelial cells in order
to prevent cell adhesion [12, 13]. It is well recognized
that exposure to oxidized lipoprotein [14, 15] or tumor
necrosis factor-a [16, 17] can reduce the thickness of
the EGx. Ischemia/reperfusion [7, 18-20] as well as
excretion of atrial natriuretic peptide [6, 21] induces
shedding of the EGx. this degradation of the EGx
is associated with an increase of the major EGx com-
ponents heparan sulfate (HS) and syndecan-1 in the
circulating blood. 
these new findings [22-24] suggest an alteration of
the EGx by endotoxemia. Hence, the aim of the cur-
rent experimental study was to explore, whether the
application of bacterial endotoxin in an animal model,
causes  destruction  of  the  EGx  and,  therefore,  the
vascular  barrier.  after  endotoxin  administration  we
measured serum concentrations of HS being one of
the main components of the EGx as target parameter
of the investigation. 
MatERIal and MEtHodS
the investigation conforms to the Guide for the Care
and Use of  Laboratory Animals published by the uS
national Institutes of Health. the study was approved
by the officially installed, independent Ethics Commit-
tee of the State of Bavaria and by the Bavarian Gov-
ernment (both Munich, Germany). It was conducted
in 15 pigs (German landrace; body weight 29 ﾱ 4.2
kg), which were treated and housed in accordance with
the principles of laboratory animal care.
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In order to maintain stable hemodynamic conditions
during endotoxemia, the animals had to be monitored:
for measurement of arterial blood pressure and left
ventricular enddiastolic pressure a femoral arterial in-
troducer sheath (8.5 french; arrow, Reading, Pa) as
well  as  a  thermodilution  pulmonary  artery  catheter
(7.5 french, REf-1; Baxter, Irvine, Ca) were inserted.
a  central  venous  catheter  (14  gauge;  arrow;  vena
femoralis) allowed for continuous drug administration.
In order to guaranty normal respiratory conditions the
animals  were  anesthetized  and  artificially  ventilated
during the procedure (airway pressures of 28 ﾱ 3 / 11
ﾱ 2 / 5 ﾱ 1 at peak / mean / end-expiration; con-
trolled  minute  ventilation  at  a  fractional  inspiratory
oxygen concentration of 1.0, Servo 900 B; Siemens,
Solna, Sweden). 
Anesthesia:
after the pigs were fasted for one night with free access
to water, intramuscular premedication was performed
with midazolam (1 mg/kg) and ketamine (10 mg/kg).
anesthesia  was  induced  by  intravenous  injection  of
fentanyl (20 ﾵg/kg), propofol (3 mg/kg), and muscular
paralysis was induced by a single dose of atracurium
besilate (0.7 mg/kg). total intravenous anesthesia was
maintained  by  continuous  intravenous  infusion  of
propofol (10 mg/kg•h, midazolam (1.5 mg/kg•h), and
fentanyl  (45  ﾵg/kg•h).  Based  on  repeated  blood  gas
analyses,  minute  ventilation  was  adjusted  to  preserve
normocapnia. normothermia was ensured by means of
a warming pad and a warming lamp.
Fluid Therapy: 
We used Ringer’s solution for fluid replacement (15
ml/kg•h). additional ﬂuid therapy consisting to equal
parts  of  Ringer’s  solution  and  pentastarch  (6%  hy-
droxyethyl  starch  200,000/0.5;  fresenius-Kabi,  Bad
Homburg, Germany) was given at constant rates up to
60 ml/kg•h, as necessary to maintain a constant left
ventricular preload (end-diastolic pressure 8 mmHg).
However,  the  administration  of  fluid  boluses  was
avoided. Intravenous norepinephrine was given con-
tinuously as necessary to maintain mean arterial pres-
sure at 70 mmHg. 
after randomization using closed envelopes we ad-
ministered  endotoxin  of  Escherichia  coli  111:B4;  1
mg/kg•h for 1 h and afterwards 10 mg/kg•h for 5 h
via the central intravenous line in 8 animals (endotoxin
group (EG)). 7 animals were observed over time with-
out further intervention (control group (CG)). In addi-
tion,  hemodynamic  parameters  (mean  arterial  blood
pressure (MaP), left ventricular enddiastolic pressure
(lvEdP),  as  well  as  ventilatory  parameters  (Pao2,
PaCo2, minute-ventilation) were recorded continuous-
ly. 
Measurements: 
We assessed serum heparan sulfate , white blood cell
count (WBC), platelet count (Plt) and serum hemo-
globin concentrations at baseline (t0) i.e. immediately
before endotoxin administration, as well as 3 h (t1)
and 6 h (t2) after the start of endotoxin administra-
tion. tumor necrosis factor-a (tnfa) and interleukin
6 (Il-6) were measured at baseline and 6 h after the
start of the endotoxin administration. HS concentra-
tions were measured using ElISa-kits (Seikagaku Inc.,
Japan) as described in detail elsewhere [4, 6].
Statistical Analysis:
Physiological data were tested for normal distribution
with  a  Kolmogorov-Smirnov-test.  Because  most  of
the data were distributed normally, they are presented
as  mean  ﾱ  standard  deviation.  We  used  a  repeated
measurement analysis of variances (RM-anova) fol-
lowed by a Student-newman-Keuls test to describe
changes of measurement parameters within a group
during the course of time (3 points of measurement).
Equality of co-variances was tested with help of the
Box-M Statistic followed by Mauchly’s test to check
for sphericity and used the Greenhouse-Geisser-Ep-
silon correction if necessary. In the case of not nor-
mally  distributed  data  we  practised  a  repeated  mea-
surement anova on ranks (friedman test). 
In  order  to  compare  differences  between  the
groups  a  RM-anova  was  followed  by  a  Student-
newmann-Keuls  test  (see  above).  If  data  were  not
normally  distributed  a  one  way  anova  on  ranks
(Kruskal-Wallace test) was followed by dunn’s test.
for all determinations a type I error protection of p <
0.05 was considered significant. Statistical analysis was
performed  using  Sigma  Stat  Software  version  3.1
(RockWare Inc. Golden, uSa), SPSS Software version
15.0.1 (SPSS Inc. Chicago, uSa) and Microsoft Excel
version 2003 (Microsoft deutschland GmbH, unter-
schlei￟heim, Germany).
RESultS
at baseline, values displayed no differences between
the groups. In 8 animals, endotoxin was administered
and a complete data set was obtained.
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Fig. 1. time course of serum heparan sulfate concentrations
after administration of endotoxin (t0). Endotoxin group: # :
p < 0.001 for t2 versus t0; p < 0.001 for t2 versus t1.
Comparison between groups: $: p < 0.001 for t2. t0: Base-
line, immediately before endotoxin administration; t1: 3 h af-
ter endotoxin administration; t2: 6 h after endotoxin admin-
istration. values are mean ﾱ Sd 
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Table 1. laboratory Parameters. 
Time Point of Measurement
Baseline 3 h after Endotoxin 6 h after Endotoxin
WBC [1000/mm3]
Endotoxin* 8.4 ﾱ 3.7 5.3 ﾱ 1.7# 1.5 ﾱ 0.3#
Control 7.6 ﾱ 1.9 8.2 ﾱ 3.1 9.0 ﾱ 3.2
Plt [1000/mm3]
Endotoxin* 270.6 ﾱ 35.9 191.6 ﾱ 80.9 93.0 ﾱ 35.5#
Control 307.0 ﾱ 132.5 254.7 ﾱ 135.5 206.7 ﾱ 70.5
Il6 [pg/ml]
Endotoxin* 2.3 ﾱ 4.7 n.d.  3810.6 ﾱ 90.6#
Control* 2.0 ﾱ 1.2 n.d. 75.2 ﾱ 67.1
tnf-a [pg/ml]
Endotoxin* 196.3 ﾱ 116.7 n.d. 1921.2 ﾱ 512.4#
Control 106.9 ﾱ 36.6 n.d. 136.9 ﾱ 293.3
Hb [g/dl]
Endotoxin 8.4 ﾱ 0.8 9.0 ﾱ 0.7 8.5 ﾱ 1.5
Control 9.2 ﾱ 0.5 9.0 ﾱ 0.5 9.0 ﾱ 0.5
*  Significant intragroup changes over time (p < 0.05). 
#  Significant differences between groups at the referring time points of measurement (p < 0.05).
n.d.  not done; WBC = White Blood Cell Count; Plt = Platelet Count; Il6 = Interleukin-6 ; tnf-a = tumor-necrosis-factor
alpha ; Hb = Hemoglobin 
Table 2. Pulmonary Gas Exchange and Hemodynamics.
Time Point of Measurement
Baseline 3h after Endotoxin 6h after Endotoxin
Pao2, [mmHg]
Endotoxin* 572.2 ﾱ 36.1 342.1 ﾱ 113.5# 225.2 ﾱ 157.7#
Control 603.1 ﾱ 42,2 610.4 ﾱ 48.6 628.2 ﾱ 41.2
PaCo2 [mmHg]
Endotoxin* 34.4 ﾱ 7.8 48.1 ﾱ 7.4# 62.1 ﾱ 18.5#
Control 30.5 ﾱ 5.6 28.0 ﾱ 5.1 28.7 ﾱ 5.8
Minute ventilation [ml/kg.min]
Endotoxin 223.1 ﾱ 43.8 244.9 ﾱ 30.8 234.9 ﾱ 57.9
Control  224.9 ﾱ 50.5 219.4 ﾱ 41.6 221.0 ﾱ 49.3
Peak airway pressure [mbar]
Endotoxin* 26.4 ﾱ 3.3 37.6 ﾱ 3.9 53.6 ﾱ 10.7#
Control* 29.4 ﾱ 2.4 32.0 ﾱ 2.8 36.9 ﾱ 5.2
norepinephrine requirements [mg/h]
Endotoxin 0.15 ﾱ 0.09# 0.05 ﾱ 0.04 0.15 ﾱ 0.12#
Control 0.0 0.0 0.0
MaP [mmHg]
Endotoxin 72.3 ﾱ 7.3 67.0 ﾱ 9.2 67.6 ﾱ 11.3
Control 90.1 ﾱ 12.2 82.1 ﾱ 9.6 72.5 ﾱ 8.4
Heart Rate [min-1]
Endotoxin* 86 ﾱ 17 110 ﾱ 17 124 ﾱ 20#
Control* 90 ﾱ 12 82 ﾱ 9 78 ﾱ 13
lvEdP [mmHg]
Endotoxin 9.0 ﾱ 1.2 9.1 ﾱ 1.3 9.0 ﾱ 2.1
Control 8.4 ﾱ 0.2 8.3 ﾱ 0.7 8.3 ﾱ 0.4
*  Significant changes over time within a group (p < 0.05). #  Significant differences between groups at the referring time points
of measurement (p < 0.05). 
Pao2: arterial oxygen tension; PaCo2: arterial carbondioxid tension; MaP: Mean arterial blood pressure; lvEdP: left ven-
tricular enddiastolic blood pressure 
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Serum HS concentrations did not change in the CG
during  the  observation  period,  but  significantly  in-
creased over time in the EG (p < 0.001, t2). (fig. 1).
Markers of  Inflammation:
In accordance with respiratory and hemodynamic pa-
rameters baseline values displayed no differences be-
tween the groups (table 1). In the control group we
noticed  a  moderate,  but  significant  increase  in  Il6
plasma concentration over time, whereas no relevant
alterations of WBC, PltS and tnf-a were observed.
In contrast, in the endotoxin group all these inflam-
mation  markers  significantly  changed  compared  to
baseline and compared to the control group (table 1).
Mean serum hemoglobin concentrations (table 1) and
hematocrit  (not  shown)  did  not  differ  significantly
throughout the study. 
Pulmonary Gas Exchange and Hemodynamics: 
all  respiratory  and  ventilatory  parameters  (except
minute  ventilation)  significantly  declined  in  the  EG
compared  to  the  CG  (table  2).  MaP  and  lvEdP
were kept at a constant level in both study groups, but,
with  proceeding  systemic  inﬂammation,  significantly
increased  ﬂuid  and  catecholamine  application  rates
were  necessary  to  maintain  stable  hemodynamics  in
the EG (table 2). during the observation period, cu-
mulative  ﬂuid  requirements  to  keep  left  ventricular
end-diastolic pressure at 8 mmHg were 1810 ml (EG)
versus 600 ml (CG) (p < 0.05). 
dISCuSSIon
the EGx is a vulnerable structure that can be dam-
aged by various pathomechanisms, which are of con-
siderable  clinical  relevance,  such  as  ischemia  and
reperfusion [20, 25]. the loss of EGx components
(HS, Syndecan-1) was observed after exposure to a va-
riety  of  stimuli  including  the  cytokines  Il-1b and
tnf-a [16], neutrophil-activation [26, 27] or human
oxidized ldl [15, 28, 29]. 
Klein et al. [26, 27, 30] demonstrated in  an  vitro
model on cultured human umbilical vein endothelial
cells  that  activated  neutrophils  pre-treated with  Es-
cherichia  coli endotoxin  caused  a  reduction  of  en-
dothelial GaGs. In this investigation, an animal mod-
el, which is easier to control than a clinical trial but
nevertheless  is  stronger  related  to  clinical  medicine
than in vitro studies, was applied. the study was de-
signed to be a starting point for further investigations
concerning the relationship between sepsis and EGx-
pathology.  according  to  its  design  the  investigation
was solely descriptive. 
the main findings of the current study were that
the administration of bacterial endotoxins to healthy,
anesthetized pigs led to a significant increase in serum
HS concentrations and that animals in the EG required
three  times  the  amount  of  intravenous  fluids  com-
pared to the CG to maintain stable hemodynamics. 
Independent  of  the  importance  intracellular  en-
dothelial structures have for vascular integrity, it has
been shown that the EGx serves as a first barrier to
prevent fluid losses from the intravascular space to the
interstitium [1, 30-32] and that even the Starling model
of transendothelial fluid exchange might have to be
redefined. In a study performed by van den Bergh et
al. [32] only the intact EGx protected against myocar-
dial edema and one can speculate that this observation
might have general validity for the whole vascular bed.
the results of the current study are indicating that the
EGx gets damaged in the presence of bacterial endo-
toxins, thus leading to an enhanced vascular perme-
ability. this should be of special interest in septicemia
because  a  capillary  leak  syndrome  with  generalized
edema is one of the most frequent symptoms of sep-
sis. Interestingly hemoglobin and hematocrit did not
change significantly during the time course in the EG.
obviously  a  relevant  hemodilution  did  not  occur  in
this group despite the heavily increased amount of in-
travenous fluid substitution. though the actual blood
volume was not measured in the current investigation,
one can speculate that fluids that were administered
via an intravenous line instantly left the intravascular
system because of a “capillary leak” caused by a defect
EGx.  on  the  other  hand,  HS  concentrations  were
only weakly correlated with fluid requirements neces-
sary to keep a constant lvEdP (r = 0.29). this weak
coherency  emphasizes  the  assumption  that  shedding
of the EGx is only one of the multiple factors deter-
mining fluid loss and fluid requirements in sepsis. 
despite the fact that there are some pathophysio-
logical differences between endotoxemia and clinical
sepsis, in the current study, Il6 and tnf-a were sig-
nificantly elevated in the EG. It is well known, that the
local  injection  of  pure  inflammatory  mediators  in-
duces  venular  leakage  [33]  and  several  investigators
found that tnf-a causes a diminution of the EGx in
in vitro models [17, 26]. In our study we could not dif-
ferentiate, whether the destruction of the EGx was
directly caused by endotoxins or by tnf-a, whose re-
lease  was  triggered  by  bacterial  lipopolysaccharides.
this question will be of interest in further studies, be-
cause tnf-a serum concentration might be a target
of therapeutical approaches in the future. Concerning
the integrity of the EGx Hydrocortisol as well as an-
tithrombin III have shown to be protective in an iso-
lated ischemic heart model [16, 20]. further research
will show whether these substances are able to prevent
shedding of the EGx in endotoxemia, too.
In two clinical studies on septic patients oragui [34]
and nelson [35] observed increased plasma-and urine
concentrations of GaGs (and Syndecan-1) and related
these to changes in glomerular permeability as well as
to  overall  mortality  and  the  antibacterial  actions  of
plasma. 
However,  these  investigations  had  some  restric-
tions: Especially in oragui’s investigation the diagnosis
“sepsis” was exclusively based on clinical symptoms as
described  by  the  american  College  of  Chest  Physi-
cians/Society  of  Critical  Care  Medicine  Consensus
Conference in 1992 [36], whereas nelson also mea-
sured C-reactive protein and procalcitonin to obtain
an increased level of diagnostic security. In both trials
the  diagnosis  “sepsis”  and  was  not  confirmed  by
blood  cultures  and  -  as  a  consequence  -  “endotox-
emia” could not be attested without doubt. the results
of  the  current  investigation  support  the  findings  of
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oragui and nelson on a more experimental basis, ex-
plicitly  demonstrating  that  bacterial  endotoxins  can
damage the EGx to a so far undefined extend. Coex-
isting conditions, like previous illnesses, age, surgical
therapy, drug therapy and others, whose influence on
the EGx is entirely unknown and which can never be
excluded completely in clinical trials could be reduced
to  two  items:  anesthesia  and  artificial  ventilation.
However,  these  factors  were  standardized  in  both
study groups and should not have influenced the inter-
group comparison. 
In contrast to rising Serum HS-levels we noticed a
considerable decrease of serum leukocyte- and platelet
counts during the 6h observation period; a phenome-
non  which  regularly  occurs  in  severe  early  sepsis.
there is some information in the literature that there
might be causal relationship between a degradation of
the EGx and leukocyte-adhesion. for example vink
[15] and  Constantinescu [29] observed that a degrada-
tion of the EGx stimulates leukocyte and platelet-en-
dothelial  cell  adhesion.  furthermore,  they  observed
that  the  systemic  leukocyte  counts  moderately  de-
creased after a systemic, additional bolus of oxidized
ldl  indicating  that  leukocyte  immobilization  oc-
curred in multiple organs, which probably induced a
depletion of the leukocyte rolling bloodstream. In ac-
cordance with the descriptive character of the study
we regard the changes in leukocyte and platelet counts
as an interesting phenomenon, worthwhile to report,
but abstained from practising statistical tests or specu-
lations on the physiological basis of this effect. this
has to be determined in further studies. 
ConCluSIon
In an animal model, the administration of bacterial en-
dotoxins  caused  significantly  elevated  levels  of  Il6
and  tnf-a and  was  accompanied  by  a  relevant  in-
crease in serum-heparan sulfate concentrations as well
as  decreased  leukocyte  and  platelet  counts.  further
studies will be necessary to investigate whether this re-
sult is reproducible in humans, and will be helpful in
diagnostics and/or therapy of septic diseases. 
the results of the study presented in the current work were
worked out in the Clinic of anesthesia, ludwig-Maximilians-
university, City of Munich, Germany.
this work was supported by a grant from the Scientific Edi-
torial Board of the Munich Medical Weekly, Munich, Bavaria,
Germany. drager-Werke (l￼beck, Germany) provided tech-
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